Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens

Transcriptase Inhibitor ◽

Highly Active ◽

Second-line protease inhibitor-based highly active antiretroviral therapy after failing non-nucleoside reverse transcriptase inhibitor-based regimens in Asian HIV-infected children

Antiviral Therapy ◽

10.3851/imp2494 ◽

2013 ◽

Vol 18 (4) ◽

pp. 591-598 ◽

Cited By ~ 8

Author(s):

Torsak Bunupuradah ◽

◽

Thanyawee Puthanakit ◽

Paul Fahey ◽

Azar Kariminia ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Second Line ◽

Highly Active ◽

Relapse of Kaposi's sarcoma in HIV-infected patients switching from a protease inhibitor to a non-nucleoside reverse transcriptase inhibitor-based highly active antiretroviral therapy regimen

AIDS ◽

10.1097/00002030-200307040-00028 ◽

2003 ◽

Vol 17 (10) ◽

pp. 1580-1581 ◽

Cited By ~ 16

Author(s):

Firouzé Bani-Sadr ◽

Sandra Fournier ◽

Jean Michel Molina

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Kaposi's Sarcoma ◽

Transcriptase Inhibitor ◽

Therapy Regimen ◽

Highly Active ◽

P44 Assessment of b-chemokines in HIV-1-infected individuals: impact of protease inhibitor (PI) vs. non-nucleoside reverse transcriptase inhibitor (NNRTI)-based highly active antiretroviral therapy (HAART)

HIV Medicine ◽

10.1046/j.1468-1293.2000.00024-135.x ◽

2000 ◽

Vol 1 (3) ◽

pp. 186-186

Author(s):

Ct Burton ◽

L Davis ◽

G Hardy ◽

Ak Sullivan ◽

M Nelson ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Reverse Transcriptase Inhibitor ◽

Hiv 1

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(08)70448-9 ◽

2007 ◽

Vol 2007 ◽

pp. 155-156

Author(s):

B.H. Thiers

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Meta Analyses ◽

Time to discontinuation of the first highly active antiretroviral therapy regimen: a comparison between protease inhibitor- and non-nucleoside reverse transcriptase inhibitor-containing regimens

AIDS ◽

10.1097/00002030-200109070-00020 ◽

2001 ◽

Vol 15 (13) ◽

pp. 1733-1736 ◽

Cited By ~ 29

Author(s):

Maria Dorrucci ◽

Patrizio Pezzotti ◽

Benvenuto Grisorio ◽

Cristina Minardi ◽

M. Stella Muro ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Therapy Regimen ◽

Highly Active ◽

Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses

The Lancet ◽

10.1016/s0140-6736(06)69638-4 ◽

2006 ◽

Vol 368 (9546) ◽

pp. 1503-1515 ◽

Cited By ~ 74

Author(s):

Roger Chou ◽

Rongwei Fu ◽

Laurie Hoyt Huffman ◽

P Todd Korthuis

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Meta Analyses ◽

Initial highly-active antiretroviral therapy with a protease inhibitor versus a nonnucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect metaanalyses

Yearbook of Medicine ◽

10.1016/s0084-3873(08)70040-3 ◽

2007 ◽

Vol 2007 ◽

pp. 61-62

Author(s):

D.R. Snydman

Keyword(s):

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Nonnucleoside Reverse Transcriptase Inhibitor ◽

EFFICACY OF NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR-BASED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY IN THAI HIV-INFECTED CHILDREN AGED TWO YEARS OR LESS

The Pediatric Infectious Disease Journal ◽

10.1097/inf.0b013e31818dd72b ◽

2009 ◽

Vol 28 (3) ◽

pp. 246-248 ◽

Cited By ~ 10

Author(s):

Thanyawee Puthanakit ◽

Linda Aurpibul ◽

Thira Sirisanthana ◽

Virat Sirisanthana

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Highly Active ◽

Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial*

HIV Medicine ◽

10.1111/j.1468-1293.2010.00864.x ◽

2010 ◽

Vol 12 (3) ◽

pp. 157-165 ◽

Cited By ~ 44

Author(s):

AB Hansen ◽

N Obel ◽

H Nielsen ◽

C Pedersen ◽

J Gerstoft

Keyword(s):

Bone Mineral Density ◽

Antiretroviral Therapy ◽

Protease Inhibitor ◽

Randomized Trial ◽

Transcriptase Inhibitor ◽

Mineral Density ◽

Highly Active ◽

Comparison of metabolic abnormalities 48 weeks after switching from highly active antiretroviral therapy containing a non-nucleoside reverse transcriptase inhibitor to Trizivir versus continued highly active antiretroviral therapy

AIDS ◽

10.1097/00002030-200308150-00017 ◽

2003 ◽

Vol 17 (12) ◽

pp. 1855-1856 ◽

Cited By ~ 7

Author(s):

C Katlama ◽

B Gazzard ◽

J Mallolas ◽

D Schürmann ◽

M Moroni ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Transcriptase Inhibitor ◽

Metabolic Abnormalities ◽

Highly Active ◽